EP Patent

EP1742616B1 — Sustained-release microspheres and methods of making and using same

Assigned to Abraxis Bioscience LLC · Expires 2014-10-01 · 12y expired

What this patent protects

Patent listed against Risperdal.

Drugs covered by this patent

Patent Metadata

Patent number
EP1742616B1
Jurisdiction
EP
Classification
—
Expires
2014-10-01
Drug substance claim
No
Drug product claim
No
Assignee
Abraxis Bioscience LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.